UK's MHRA Unveils Stricter Review Policy for DTC Ads

Drug Industry Daily
A A

The UK’s health watchdog is ratcheting up enforcement of misleading drug promotions, announcing this week that it intends to review all promotional materials for newly licensed medicines before they are disseminated.

To View This Article:

Login

Subscribe To Drug Industry Daily